Kim Williams
In the complex landscape of clinical trials, where success hinges on meticulous planning, seamless execution, and patient-centricity, the decision of which eCOA/ePRO clinical trial vendor to partner with can be a pivotal one. Often, this choice is fraught with the dichotomy between perceived risk and actual risk – the tension between what appears to be …
Diabetes research stands at the crossroads of innovation and necessity, seeking to unravel effective strategies for managing this prevalent condition. Beyond medical interventions, integrating lifestyle changes and behavioral adjustments has emerged as a pivotal aspect of these research endeavors. In this evolving landscape, integrating electronic Clinical Outcome Assessments (eCOA) and patient engagement is emerging as …
The importance of patient experiences in clinical trials cannot be overstated. Patient participation fuels medical research advancement and plays a pivotal role in determining a sponsor’s Return on Investment (ROI). However, as we delve into this intricate web of patient engagement, recruitment, and retention, we uncover a critical question: Why do sponsors sometimes lean toward …
Generally a requirement in clinical research, electronic clinical outcomes assessments (eCOA) come with their own set of acronyms. Let’s dive into some of the most commonly used assessments, their significance, and the types of trials that can benefit the most from their implementation. Acronyms C-SSRS (Columbia-Suicide Severity Rating Scale) The C-SSRS is a validated tool …
The digital revolution has disrupted traditional norms in various sectors, leading to innovative approaches in both employment and healthcare. Remote work has gained immense popularity over the years. It’s empowered employees to work from the comfort of their homes. Likewise, the concept of decentralized clinical trials is transforming the landscape of patient participation in research …
In the field of clinical trials, we’re witnessing a paradigm shift. The landscape is changing rapidly, and a significant part of this transformation stems from an increased focus on the patient experience. A prime example of this shift is the innovative approach of Patient Journey Mapping, a tool that helps researchers to understand the patient’s …
With decades of clinical trial experience, I have witnessed firsthand the impact that patient retention and compliance have on clinical trial success. In a world where trial costs continue to rise and timelines get tighter, the need for effective patient engagement strategies has never been more crucial. In this article, I will share some valuable …
Clinical trials for rare diseases face unique challenges, such as small patient populations and limited access to treatment options. With this in mind, behavioral science principles and technological advancements can help improve outcomes in rare disease clinical trials. Here are five ways behavioral science and technology can help: Enhance patient engagement with behavioral science principles …
Cell and gene therapy have been among the most promising medical technologies in recent years. As well as the potential to revolutionize the treatment of many diseases. However, the success of clinical trials for these therapies can be affected by a number of factors. These factors include patient recruitment and retention, adherence to treatment protocols, …
Medication adherence is a critical aspect of clinical trials. It can significantly impact the trial’s outcome and the ability to draw accurate conclusions from the data. Adherence refers to the extent to which a patient follows the prescribed treatment regimen, including taking medication, keeping appointments, and following other recommended therapies. For a clinical study to …